Compare AU
Compare IZZ vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the FTSE China 50 (IZZ) and the S&P Global 1200 Healthcare (IXJ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
IZZ | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 31 | 241 |
Median incremental investment | $2,600.00 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,931.20 | $1,668.00 |
Average age group | > 35 | 26 - 35 |
Key Summary
IZZ | IXJ | |
|---|---|---|
Strategy | IZZ.AX was created on 2004-10-05 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to provide investors with the performance of the FTSE China 50 Index, before fees and expenses. The index is designed to measure the performance of 50 of the largest and most liquid Chinese companies which trade on the Hong Kong Stock Exchange | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks |
Top 3 holdings | MEITUAN (10.47 %) ALIBABA GROUP HOLDING LTD (8.86 %) TENCENT HOLDINGS LTD (8.29 %) | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) |
Top 3 industries | Other (58.33 %) Consumer Discretionary (21.66 %) Communication Services (10.44 %) | Other (99.98 %) Communication Services (0.02 %) |
Top 3 countries | China (100.00 %) | United States (99.97 %) |
Management fee | 0.74 % | 0.46 % |
Key Summary
IZZ | IXJ | |
|---|---|---|
Issuer | iShares | iShares |
Tracking index | FTSE China 50 Net Tax USD Index | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.74 % | 0.46 % |
Price | $49.14 | $139.00 |
Size | $328.312 million | $1.414 billion |
10Y return | 2.23 % | 126.37 % |
Annual distribution yield (5Y) | 1.97 % | 1.26 % |
Market | ASX | ASX |
First listed date | 15/11/2007 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IZZ | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 31 | 241 |
Median incremental investment | $2,600.00 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $3,931.20 | $1,668.00 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
IZZ | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
IZZ | IXJ |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |